[Blood substitution in surgery].
Bardenheuer
M
M
Klinik für Unfallchirurgie, Universitätsklinikum Mannheim, 68135 Mannheim. mark.bardenheuer@uch.ma.uni-heidelberg.de
Frilling
A
A
Massoudy
P
P
Waydhas
C
C
Nast-Kolb
D
D
D000328:Adult; D000818:Animals; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001777:Blood Coagulation; D016913:Blood Component Transfusion; D001803:Blood Transfusion; D001804:Blood Transfusion, Autologous; D002648:Child; D018849:Controlled Clinical Trials as Topic; D017707:Erythrocyte Transfusion; D004921:Erythropoietin / Q000008:administration & dosage; D005260:Female; D006438:Hemodilution; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D017713:Platelet Transfusion; D011247:Pregnancy; D011300:Preoperative Care; D012189:Retrospective Studies; D012307:Risk Factors; D013514:Surgical Procedures, Operative; D065227:Transfusion Reaction; D015599:Trauma Severity Indices; D014947:Wounds and Injuries / Q000628:therapy
D000933:Antifibrinolytic Agents; D006454:Hemoglobins; D004921:Erythropoietin